Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 18 | 2022 | 384 | 4.460 |
Why?
|
| Blood Preservation | 7 | 2022 | 300 | 1.940 |
Why?
|
| Cryopreservation | 3 | 2022 | 109 | 1.310 |
Why?
|
| Platelet Aggregation | 6 | 2020 | 86 | 1.300 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2013 | 403 | 0.840 |
Why?
|
| Hemostasis | 4 | 2018 | 60 | 0.790 |
Why?
|
| Suntan | 1 | 2019 | 1 | 0.780 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2013 | 445 | 0.780 |
Why?
|
| Platelet Transfusion | 2 | 2020 | 66 | 0.770 |
Why?
|
| Platelet Membrane Glycoproteins | 5 | 2013 | 47 | 0.720 |
Why?
|
| Bleeding Time | 2 | 2015 | 4 | 0.610 |
Why?
|
| Saphenous Vein | 2 | 2015 | 36 | 0.600 |
Why?
|
| Receptors, Thrombin | 2 | 2013 | 14 | 0.540 |
Why?
|
| Vascular System Injuries | 1 | 2015 | 56 | 0.540 |
Why?
|
| Dextran Sulfate | 1 | 2013 | 73 | 0.500 |
Why?
|
| Blood Coagulation | 4 | 2019 | 216 | 0.490 |
Why?
|
| Threonine | 2 | 2010 | 53 | 0.450 |
Why?
|
| Blood Component Removal | 2 | 2022 | 33 | 0.430 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 356 | 0.430 |
Why?
|
| Flow Cytometry | 5 | 2019 | 1170 | 0.430 |
Why?
|
| Myosin Light Chains | 1 | 2010 | 34 | 0.420 |
Why?
|
| Carbazoles | 1 | 2011 | 93 | 0.420 |
Why?
|
| Plateletpheresis | 3 | 2022 | 30 | 0.420 |
Why?
|
| Serine | 1 | 2010 | 134 | 0.400 |
Why?
|
| Apoptosis | 1 | 2019 | 2609 | 0.370 |
Why?
|
| Platelet Activation | 6 | 2015 | 58 | 0.350 |
Why?
|
| Cold Temperature | 2 | 2020 | 156 | 0.340 |
Why?
|
| Thromboplastin | 2 | 2015 | 33 | 0.290 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 548 | 0.280 |
Why?
|
| Syk Kinase | 3 | 2013 | 18 | 0.270 |
Why?
|
| Lectins, C-Type | 3 | 2013 | 72 | 0.260 |
Why?
|
| Thrombosis | 2 | 2015 | 267 | 0.230 |
Why?
|
| Ticlopidine | 3 | 2015 | 68 | 0.210 |
Why?
|
| Mice, Knockout | 7 | 2018 | 2827 | 0.200 |
Why?
|
| Quinolines | 1 | 2020 | 140 | 0.190 |
Why?
|
| Factor IX | 2 | 2018 | 8 | 0.190 |
Why?
|
| Platelet Count | 1 | 2019 | 85 | 0.190 |
Why?
|
| Hemostatics | 1 | 2019 | 43 | 0.190 |
Why?
|
| Isoenzymes | 2 | 2011 | 356 | 0.180 |
Why?
|
| Factor IXa | 1 | 2018 | 1 | 0.180 |
Why?
|
| Protein S | 1 | 2018 | 7 | 0.180 |
Why?
|
| Hemophilia B | 1 | 2018 | 14 | 0.180 |
Why?
|
| Protein Kinase C | 2 | 2011 | 352 | 0.170 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2019 | 577 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2015 | 386 | 0.170 |
Why?
|
| Lactic Acid | 1 | 2019 | 294 | 0.170 |
Why?
|
| Calcium | 3 | 2013 | 1195 | 0.160 |
Why?
|
| Heparin | 1 | 2018 | 222 | 0.160 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2016 | 25 | 0.160 |
Why?
|
| Refrigeration | 1 | 2016 | 10 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 134 | 0.150 |
Why?
|
| Solutions | 1 | 2016 | 186 | 0.150 |
Why?
|
| Humans | 19 | 2022 | 113890 | 0.150 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2015 | 7 | 0.150 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2015 | 3 | 0.150 |
Why?
|
| Talin | 1 | 2015 | 8 | 0.150 |
Why?
|
| Platelet Adhesiveness | 1 | 2015 | 13 | 0.150 |
Why?
|
| Microscopy, Video | 1 | 2015 | 25 | 0.140 |
Why?
|
| Cell-Derived Microparticles | 1 | 2015 | 61 | 0.140 |
Why?
|
| Intravital Microscopy | 1 | 2015 | 20 | 0.140 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 67 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 5 | 2018 | 5143 | 0.140 |
Why?
|
| Fibrin | 1 | 2015 | 52 | 0.140 |
Why?
|
| Fibrinogens, Abnormal | 1 | 2014 | 4 | 0.140 |
Why?
|
| Skin | 1 | 2019 | 687 | 0.130 |
Why?
|
| Phosphorylation | 4 | 2013 | 1729 | 0.130 |
Why?
|
| Laser Therapy | 1 | 2015 | 97 | 0.130 |
Why?
|
| Glucose | 1 | 2019 | 893 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 2185 | 0.130 |
Why?
|
| Crotalid Venoms | 2 | 2011 | 36 | 0.130 |
Why?
|
| Mitochondria | 2 | 2019 | 812 | 0.130 |
Why?
|
| Peptides, Cyclic | 2 | 2013 | 262 | 0.130 |
Why?
|
| Fibrinogen | 1 | 2014 | 158 | 0.130 |
Why?
|
| Bacteria | 1 | 2019 | 662 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 440 | 0.120 |
Why?
|
| Signal Transduction | 5 | 2013 | 4887 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2013 | 80 | 0.120 |
Why?
|
| Arteries | 1 | 2014 | 236 | 0.120 |
Why?
|
| Tyrosine | 1 | 2013 | 240 | 0.120 |
Why?
|
| Animals | 11 | 2018 | 34695 | 0.120 |
Why?
|
| Mice | 9 | 2015 | 15400 | 0.110 |
Why?
|
| Protein Binding | 2 | 2018 | 2058 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2013 | 191 | 0.110 |
Why?
|
| Cell Shape | 1 | 2010 | 56 | 0.110 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 92 | 0.100 |
Why?
|
| Peptides | 3 | 2011 | 865 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2019 | 4287 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 496 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 7011 | 0.100 |
Why?
|
| Amino Acids, Aromatic | 1 | 2009 | 8 | 0.100 |
Why?
|
| rho-Associated Kinases | 1 | 2010 | 87 | 0.100 |
Why?
|
| Collagen Type IV | 1 | 2009 | 23 | 0.100 |
Why?
|
| Kinetics | 2 | 2010 | 1757 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2010 | 139 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2016 | 921 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2011 | 814 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2011 | 223 | 0.090 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 1233 | 0.090 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 79 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 3850 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2009 | 388 | 0.090 |
Why?
|
| Inflammation | 2 | 2014 | 2431 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 852 | 0.070 |
Why?
|
| Thrombin | 2 | 2015 | 125 | 0.070 |
Why?
|
| Thrombocytopenia | 2 | 2015 | 189 | 0.060 |
Why?
|
| Benzothiazoles | 1 | 2020 | 42 | 0.050 |
Why?
|
| Plasma | 1 | 2022 | 237 | 0.050 |
Why?
|
| Freeze Drying | 1 | 2019 | 160 | 0.050 |
Why?
|
| Coagulants | 1 | 2018 | 9 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2018 | 212 | 0.040 |
Why?
|
| Male | 5 | 2018 | 60623 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 137 | 0.040 |
Why?
|
| Thrombelastography | 1 | 2019 | 263 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2018 | 405 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2019 | 657 | 0.040 |
Why?
|
| Thrombopoiesis | 1 | 2015 | 6 | 0.040 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2015 | 8 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2015 | 56 | 0.040 |
Why?
|
| Splenectomy | 1 | 2015 | 50 | 0.040 |
Why?
|
| Female | 4 | 2016 | 62822 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2015 | 63 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 56 | 0.030 |
Why?
|
| Binding Sites | 1 | 2018 | 1286 | 0.030 |
Why?
|
| Antithrombins | 1 | 2014 | 57 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2015 | 172 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2015 | 146 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 361 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 176 | 0.030 |
Why?
|
| src-Family Kinases | 1 | 2013 | 94 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 447 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2013 | 211 | 0.030 |
Why?
|
| Hemophilia A | 1 | 2013 | 58 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 1138 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1316 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 218 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2010 | 26 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2013 | 327 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 275 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2010 | 116 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 388 | 0.020 |
Why?
|
| Thromboxane A2 | 1 | 2009 | 14 | 0.020 |
Why?
|
| Receptors, Proteinase-Activated | 1 | 2009 | 1 | 0.020 |
Why?
|
| Protein Kinase C-theta | 1 | 2009 | 2 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2009 | 56 | 0.020 |
Why?
|
| Qa-SNARE Proteins | 1 | 2009 | 18 | 0.020 |
Why?
|
| Crystallization | 1 | 2009 | 158 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 266 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 802 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 703 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2013 | 534 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 2872 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2009 | 465 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 2099 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 3403 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2009 | 272 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 420 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2158 | 0.020 |
Why?
|
| Gene Expression | 1 | 2010 | 1529 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2009 | 731 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 3015 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 2060 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28776 | 0.010 |
Why?
|